RecruitingNCT02880631

BAROSTIM THERAPY™ In Resistant Hypertension

BAROSTIM THERAPY™ In Resistant Hypertension: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System

Sponsor

CVRx, Inc.

Enrollment

500 participants

Start Date

Dec 13, 2016

Study Type

OBSERVATIONAL

Conditions

Hypertension

Summary

The purpose of this registry (NCT02880631) is to evaluate the effect of BAROSTIM THERAPY with the BAROSTIM NEO System in the commercial setting in subjects recently implanted under the CE-Marked indication for resistant hypertension.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called BAROSTIM NEO™ System for people with hypertension. The study is currently recruiting participants at 26 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBAROSTIM NEO™ System

Locations(26)

Charité Benjamin Franklin

Berlin, Germany

Charité Campus Virchow

Berlin, Germany

Immanuel Klinikum Bernau Herzzentrum Brandenburg

Bernau, Germany

Cloppenburg Katholische Kliniken Münsterland

Cloppenburg, Germany

Universitätsklinikum Köln Herzzentrum

Cologne, Germany

Lippe Klinikum

Detmold, Germany

Herzzentrum Dresden

Dresden, Germany

Krankenhaus Erding

Erding, Germany

Cardiovascular Center 'CVC' Frankfurt

Frankfurt, Germany

Universitätsklinikum Gießen und Marburg

Giessen, Germany

Herzzentrum Göttingen

Göttingen, Germany

Asklepios Klinik Altona

Hamburg, Germany

St. Barbara Klinik Hamm

Hamm, Germany

Kardiologie im Klinikum Ingolstadt

Ingolstadt, Germany

Universitätsklinikum Schleswig-Holstein Campus Kiel

Kiel, Germany

Herzentrum Lahr

Lahr, Germany

Universitätsklinikum Leipzig

Leipzig, Germany

Universitätsklinik Mainz

Mainz, Germany

Papenburg Marien Krankenhaus

Papenburg, Germany

Universitätsklinikum Regensburg

Regensburg, Germany

Marienkrankenhaus Siegen

Siegen, Germany

Krankenhaus & MVZ Maria-Hilf Stadtlohn GmbH

Stadtlohn, Germany

Klinikum Stuttgart

Stuttgart, Germany

Klinikum Tuttlingen

Tuttlingen, Germany

Heinrich-Braun Klinikum

Zwickau, Germany

Maastricht University Medical Center

Maastricht, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02880631

Related Trials

A Single-centre Study Evaluating the Performance and Acceptance of the Hilo Band Cuffless Blood Pressure Medical Device in the Normo-, Hypo- and Hyper-tensive Young Population: a Comparison With the 24-h Ambulatory Blood Pressure Monitoring (ABPM)

NCT07072689

A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

NCT075534423 locations

Study of Disrupted Sleep in Somali Americans

NCT054110291 location

OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device

NCT07507903

A Prospective Nurse Cohort Study in Xiamen, China

NCT037996531 location